© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Grapefruit USA, Inc. (GPFT) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 28 |
| Sep 09, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 12.56K |
| Sep 03, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 2.01M |
| Sep 02, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 13.36K |
| Sep 01, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 5.18M |
| Aug 31, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 2.6M |
| Aug 28, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 62.27K |
| Aug 27, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 8.4K |
| Aug 25, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 8.12K |
| Aug 24, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.12K |
| Aug 21, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01M |
| Aug 19, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 5K |
| Aug 14, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 8.15K |
| Aug 13, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 100K |
| Aug 12, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 9.83M |
| Aug 11, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 25.66M |
| Aug 10, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 2.77M |
| Aug 06, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 89K |
| Aug 05, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.35M |
| Aug 04, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 2K |
Grapefruit USA, Inc. is a company dedicated to the creation and distribution of cannabis-related goods, primarily serving the California market. A key offering from the firm is Hourglass, a topical cream featuring a sustained-release blend of THC and CBD, which is exclusively sold via its online platform. The business, originally established in 2017, was formerly recognized as Grapefruit Boulevard Investments, Inc., before officially adopting its current name, Grapefruit USA, Inc., in January 2020. Its main operational base is situated in Wilmington, Delaware.
| Employees | 9 |
| Beta | -0.03 |
| Sales or Revenue | $200.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |